NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/06/2026
Back to search
Official data from USPTO
ACTOLOG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACTOLOG
ST13
US500000079275292Class
5, 42, 44
Filing
79275292
Registration
6253445
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
08/06/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
10/16/2019
Registration date
01/26/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/26/2021
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
DE
Examiner
CALLOWAY, CHRISTINA DENISE
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Immatics Biotechnologies GmbH
Representatives
Anna Kurian Shaw Hogan Lovells US LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical and pharmaceutical productsoncologicalanti-viralanti-bacterial and autoimmunity pharmaceuticals and natural remedies; diagnostic reagents for medical purposes; synthetic peptidesbinding proteins and living cells for medicaldiagnostic and therapeutic purposesin particular for cancer therapy
Class 42
Medical research and pharmacological researchpharmaceutical research services; conducting research and clinical trials for others relating to the use and the engineering of t-cells and cancer treatment and therapy; scientific research in the field of chemistrybiochemistry and biology; scientific laboratory servicesbiologicalbiochemical and chemical laboratory services; biologicalbiochemical and chemical analysis; medical and scientific research in the field of cancer diagnosis; scientific laboratory servicesbiological and biochemical laboratory services; biological and biochemical examination services of specimens in the field of cancer treatment and diagnosis
Class 44
Medical servicesmedical and pharmacological diagnosis of oncologicalviralbacterialautoimmune diseases and pharmaceutical servicespharmaceutical compounding services for diagnosis and treatment of oncologicalviralbacterialautoimmune diseases; dispensing of pharmaceuticalsproviding medical supply for therapyin particular supply of synthetic peptidesbinding proteins and living cells for cancer therapy; medical diagnosis of cancer
Publications
History of USPTO decisions and trademark events.
40 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/26/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/02/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/02/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/02/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/07/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/23/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/29/2021
FIMP
FINAL DISPOSITION PROCESSED
04/29/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2021
GPNX
NOTIFICATION PROCESSED BY IB
12/12/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/25/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2020
PUBO
PUBLISHED FOR OPPOSITION
11/10/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/21/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/06/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
10/06/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/06/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
10/06/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/28/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/28/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/28/2020
RFNT
REFUSAL PROCESSED BY IB
03/21/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/02/2020
RFRR
REFUSAL PROCESSED BY MPU
03/02/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/27/2020
CNRT
NON-FINAL ACTION WRITTEN
02/26/2020
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
02/25/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/31/2020
CNRT
NON-FINAL ACTION WRITTEN
01/30/2020
DOCK
ASSIGNED TO EXAMINER
01/22/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/07/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/26/2019
Continuous trademark protection
Get notified about every new filing that threatens ACTOLOG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.